TG Therapeutics Inc
TGTX
Market Cap$2.61B
Close$
$16.18
0.7% downside
Current Fair Value
0.7% downsideOvervalued by 0.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.61 Billion |
|---|---|
| Enterprise Value | $2.50 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.28 |
| Beta | 1.37 |
| Outstanding Shares | 154,542,945 |
| Avg 30 Day Volume | 3,249,776 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 62.77 |
|---|---|
| PEG | -86.32 |
| Price to Sales | 16.3 |
| Price to Book Ratio | 16.3 |
| Enterprise Value to Revenue | 8.65 |
| Enterprise Value to EBIT | 51.74 |
| Enterprise Value to Net Income | 60 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.63 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About TG Therapeutics Inc
CEO: Michael Weiss